Menu

Omaha, NE – Streck announces the appointment of David Conrad, Ph.D., to the position of Vice President of Research & Development. In this role, Conrad will work with President and CEO Connie Ryan to drive product innovation for the Omaha-based medical device developer and manufacturer. His responsibilities include new product development as well as expansion of existing product lines.

“David has been serving Streck as a Board Member for a number of years and recently took on an additional role as a member of the Streck Scientific Advisory Committee,” said Connie Ryan, Streck President and CEO. “He is well-suited for this newly created position to lead our R&D team.” Conrad will join Streck on October 5, 2016.

Most recently, Conrad was Assistant Vice President for Economic Development at the University of Iowa where he was responsible for startup formation, technology transfer, the research park, public-private partnerships and statewide outreach to industry for economic development. As Conrad stated, his job was to create an innovative and entrepreneurial culture on campus so the discoveries made can help solve the world’s biggest problems. He’ll use that expertise to support Streck’s focus on quality and innovation within the medical health marketplace.

Prior to joining the University of Iowa, Conrad was Executive Director of NUtech Ventures, an organization that connects the innovations generated through the research activities at the University of Nebraska with the industry partners and investor resources needed to start companies, develop products and create jobs. Conrad served as Associate Vice Chancellor for Technology Development at the University of Nebraska-Lincoln from 2006 to 2013 and co-founded Emerjent, Inc., a software start-up developing predictive analytics solutions.

Conrad earned his bachelor’s degree in chemistry from University of North Carolina at Chapel Hill and his Ph.D. in chemistry from University of Illinois at Urbana-Champaign. He had a postdoctoral fellowship in chemistry at the California Institute of Technology. Conrad received his MBA from the Fuqua School of Business at Duke University.

“Conrad is a life-long advocate of innovation,” said Steve Bullock, Streck Executive Vice President, “so we believe he is a perfect match to lead the R&D team of a company known for innovative solutions and products. We are excited to have David transition from an advisory role to a more substantive position within our organization.”

About Streck, Inc.
Established in 1971, Streck develops and manufactures products for clinical and research laboratories. Streck’s passion for innovation, quality and service has allowed the organization to become a world leader in the development of quality control and diagnostic products that help laboratories ensure accurate and timely results for patients. Streck offers the industry’s leading automated erythrocyte sedimentation rate instrument and is a worldwide supplier of blood collection tubes that standardize methods for sample collection, stabilization and transportation. Expanding product lines include flow cytometry, body fluids and urinalysis with emerging products being developed for the burgeoning field of molecular diagnostics. For more information, visit www.streck.com.

What we offer

Upcoming Events >